ESR1 and breast cancer: The incidence of LC in BC is higher in younger patients and those with a larger primary tumor, advanced nodal disease, histological grade 3, negative estrogen receptor (ER), positive human epidermal growth factor receptor 2 (HER2), triple-negative type, and a high proliferative index [14].